Molecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activity
about
CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitinLigand modulation of the Epstein-Barr virus-induced seven-transmembrane receptor EBI2: identification of a potent and efficacious inverse agonistInternational Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsOrphan endogenous lipids and orphan GPCRs: a good matchDo orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimersEBI2 is a negative regulator of type I interferons in plasmacytoid and myeloid dendritic cellsMolecular characterization of oxysterol binding to the Epstein-Barr virus-induced gene 2 (GPR183)EBI2 mediates B cell segregation between the outer and centre follicleThe chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cellsOn the role of 25-hydroxycholesterol synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment.The E92K melanocortin 1 receptor mutant induces cAMP production and arrestin recruitment but not ERK activity indicating biased constitutive signalingIdentification of vascular and hematopoietic genes downstream of etsrp by deep sequencing in zebrafish.EBI2 guides serial movements of activated B cells and ligand activity is detectable in lymphoid and nonlymphoid tissues.Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptorsEBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail.Assessment of constitutive activity of a G protein-coupled receptor, CPR2, in Cryptococcus neoformans by heterologous and homologous methods.A constitutively active GPCR governs morphogenic transitions in Cryptococcus neoformansIntercellular Lipid Mediators and GPCR Drug DiscoveryImmune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunityFinding the right niche: B-cell migration in the early phases of T-dependent antibody responses.GPR18 in microglia: implications for the CNS and endocannabinoid system signallingStructural Diversity in Conserved Regions Like the DRY-Motif among Viral 7TM Receptors-A Consequence of Evolutionary Pressure?Oxysterol-EBI2 signaling in immune regulation and viral infection.Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine.The future of antiviral immunotoxins.Biased agonism and allosteric modulation of G protein-coupled receptor 183 - a 7TM receptor also known as Epstein-Barr virus-induced gene 2.Identification of a conserved gene signature associated with an exacerbated inflammatory environment in the hippocampus of aging rats.Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants.Epstein-Barr Virus-induced Gene 2 and Leukocyte Airway Recruitment in Response to Allergen Challenge.Novel Chemokine-Based Immunotoxins for Potent and Selective Targeting of Cytomegalovirus Infected Cells.Epstein-Barr Virus-induced Gene 2 Mediates Allergen-induced Leukocyte Migration into Airways.EBI2 overexpression in mice leads to B1 B-cell expansion and chronic lymphocytic leukemia-like B-cell malignancies.Small molecule antagonism of oxysterol-induced Epstein-Barr virus induced gene 2 (EBI2) activation.Unique interaction pattern for a functionally biased ghrelin receptor agonist.Prostaglandin E2 glyceryl ester is an endogenous agonist of the nucleotide receptor P2Y6The EBI2 signalling pathway plays a role in cellular crosstalk between astrocytes and macrophages.Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model.GPR183 binds 7alpha;25-dihydroxycholesterol
P2860
Q24302660-D55416CB-3D87-49B0-89A7-95EAD7CEFC7AQ24306565-56A20F85-F1EE-47AC-ACBE-4978292E9AE0Q24605072-FD076B8A-9E8B-477D-9610-A332376431D2Q24657799-8BD3A71D-F04E-4382-8B0E-8D38D762F014Q24673058-13FB3F3F-FD65-444F-8956-607386BEA6FEQ27339798-EA513BB8-7FC2-4DF1-A42A-652537F54E75Q28115398-CA16F2DB-3466-4227-92AA-5C6E0D812103Q28251850-CDCC231D-9A71-462A-86C1-44714B1F7960Q28508363-9D295F39-B1DF-4788-96A1-BC17ECCE7E7DQ33737051-5473960F-9E6C-41F4-BBD6-D955AE5EC40AQ34023834-122C6D52-314A-4281-975F-CBAF72B30C58Q34206023-CEF3EAFF-26C7-49B4-9CC5-22669D687BD8Q35204626-508659B1-3F83-4FD1-B2CF-97CCF471C727Q36497002-DD8014E7-CBE1-42E1-92A1-D65314E6CF5AQ36590231-6FDF9F4A-D05C-4CEF-A6C3-1D4421EB76E0Q36950568-45D28353-F24F-4E97-B9BE-DE02291113C7Q37194629-8C01266E-F66A-4E40-9FA0-49F6EA147A2AQ37429742-D9A02FB7-5380-4048-90A9-E06386E2C9D4Q37652046-DF29DDBA-2688-4F90-81E8-7D638BE72D8BQ37761265-D2FCC07C-4C5D-4649-A6AD-143F51A10C21Q38007991-0A1285B8-0FD2-4E98-A7BA-A5828AB51C7CQ38035296-D874C47F-A003-4C81-8998-397DDB77DDAFQ38210350-46EFD363-9709-4E60-AD75-937DD681C042Q38614708-52DBA346-75B5-4DF5-8F39-9D0C1BB2EF58Q38686601-E5D2767F-6A70-4B75-89D9-A61FE594C04BQ38859909-70D59F61-6EDF-42F9-9C8A-374EB0B83FA8Q39022267-1613F2EF-AE72-4A57-B2DF-BEBD256A7202Q39640491-26AE3441-3D52-4CFC-BDE7-BA3780A4DCEAQ40159208-0B42F17C-AFC4-4791-A87F-1E6A8D56CEF7Q40311717-631F8406-E87F-4A06-ADD6-0725B4034B43Q40363493-BB31D15D-A63F-451B-8083-4B243E98F8CDQ40400031-E9B3C6F4-1D6F-4736-AFA8-963F93EA576EQ41262687-FB92EEEB-3535-4671-9018-F67D4D184D38Q42064855-0C2C0EFF-99D2-4403-88BA-B54230B19768Q42106785-52E99438-CB34-46E6-A9CD-D5888E875A71Q42795370-D111F0D7-2DFC-49C9-AA78-E9F9587A5966Q45930874-B77231CB-1576-41C8-8E6A-333D7D33B108Q50298377-849E0ACA-B414-496A-8E8A-35E2AFBAC044
P2860
Molecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activity
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Molecular pharmacological phen ...... tor with constitutive activity
@ast
Molecular pharmacological phen ...... tor with constitutive activity
@en
Molecular pharmacological phen ...... tor with constitutive activity
@nl
type
label
Molecular pharmacological phen ...... tor with constitutive activity
@ast
Molecular pharmacological phen ...... tor with constitutive activity
@en
Molecular pharmacological phen ...... tor with constitutive activity
@nl
prefLabel
Molecular pharmacological phen ...... tor with constitutive activity
@ast
Molecular pharmacological phen ...... tor with constitutive activity
@en
Molecular pharmacological phen ...... tor with constitutive activity
@nl
P2093
P2860
P50
P3181
P356
P1476
Molecular pharmacological phen ...... tor with constitutive activity
@en
P2093
Hans R Lüttichau
Helene Andersen
Jørgen K Larsen
Tau Benned-Jensen
Thomas N Kledal
P2860
P304
P3181
P356
10.1074/JBC.M602245200
P407
P577
2006-05-12T00:00:00Z